Report of Foreign Issuer (6-k)
April 14 2020 - 6:05AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the month of April 2020
Commission File Number 001-37410
ESSA Pharma Inc.
(Translation of registrant’s name
into English)
Suite 720, 999 West Broadway, Vancouver,
British Columbia, Canada, V5Z 1K5
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x
Form 40-F ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXHIBITS INCLUDED AS PART OF THIS REPORT
Exhibit
|
|
|
|
|
|
99.1
|
|
Open Market Sale AgreementSM, dated April 13, 2020, between ESSA Pharma Inc. and Jefferies LLC.
|
99.2
|
|
Press Release dated April 13, 2020.
|
Exhibit 99.1 of this Report on Form 6-K shall be incorporated
by reference into the registrant’s Registration Statements on Form F-3 (File No. 333-234136, File No. 333-225969) and Form
S-8 (File No. 333-225056) under the Securities Act of 1933, as amended.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
ESSA PHARMA INC.
|
|
(Registrant)
|
|
|
|
Date: April 13, 2020
|
By:
|
/S/ DAVID WOOD
|
|
Name:
|
David Wood
|
|
Title:
|
Chief Financial Officer
|
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Sep 2023 to Sep 2024